Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Clinical trial NCT02068443 · COMPLETED

Trial details

NCT number: NCT02068443
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2014-02-01
Primary completion: 2015-02-01
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.